|
Press Releases
| |
|
Displaying releases:
1-15 | 16-30 | 31-45 | 46-60 | 61-75 | 76-90 | 91-105 | 106-120 | 121-135 | 136-150 | 151-165 | 166-180 | 181-195 | 196-203
|
| |
Jan-30-2004
|
Palatin Technologies, Inc. Raises $22.7 Million in Private Equity Transaction |
| |
Jan-07-2004
|
Palatin Technologies, Inc. to Sponsor “Role of Novel Mechanisms in the Treatment of Sexual Dysfunction and Palatin’s PT-141 Drug Candidate" Presentation on January 8, 2004 |
| |
Nov-17-2003
|
Palatin Technologies, Inc. Reports First Quarter Financial Results Teleconference and Webcast to be Held November 19, 2003 |
| |
Nov-06-2003
|
Palatin Technologies, Inc. to Participate in Annual CIBC World Markets Healthcare Conference |
| |
Nov-05-2003
|
Palatin Technologies, Inc. PT-141 Phase 2B Study on Erectile Dysfunction Comprehensive Overview of Results Teleconference and Webcast to be Held November 6, 2003 |
| |
Nov-05-2003
|
Palatin Technologies, Inc. Announces the Appointment of Dr. Perry Molinoff at University of Pennsylvania |
| |
Nov-03-2003
|
Palatin Technologies Meets Primary and Secondary Endpoints in PT-141 Phase 2B Study on Erectile Dysfunction |
| |
Oct-31-2003
|
Palatin Technologies, Inc. to Present Results of Phase 2b, Male Erectile Dysfunction At-Home Study at the Leadership Conference on Sexual, Cardiovascular and Metabolic Syndrome Related therapeutics |
| |
Oct-21-2003
|
Palatin Technologies to Participate in Rodman & Renshaw Techvest Healthcare Conference |
| |
Sep-30-2003
|
Palatin Technologies, Inc. Reports Fourth Quarter, Year End 2003 Results |
| |
Jul-24-2003
|
Palatin Technologies, Inc. Completes Enrollment for Phase 2B At-Home Trial of PT-141 |
| |
Jun-24-2003
|
Palatin Technologies, Inc. Issued U.S. Patent for PT-141 Novel Treatment for Male and Female Sexual Dysfunction |
| |
May-29-2003
|
Palatin Technologies Announces Teleconference and Webcast to be Held on Tuesday, June 3, 2003 |
| |
May-16-2003
|
Palatin Technologies, Inc. Reports Third Quarter Results |
| |
May-13-2003
|
Palatin Begins Enrollment in PT-141 Phase 2B At-Home Clinical Study |
| |
 |
|
|
